a2, United States Patent
`US 6,801,799 B2
`(10) Patent No.:
`Mendelson
`(45) Date of Patent:
`Oct. 5, 2004
`
`
`US006801799B2
`
`(54) PULSE OXIMETER AND METHOD OF
`OPERATION
`
`(75)
`
`Inventor: Yitzhak Mendelson, Worcester, MA
`(US)
`
`_
`.
`.
`(73) Assignee: Cybro Medical, Ltd., Haifa (IL)
`.
`.
`.
`.
`(*) Notice:
`Subjectto any disclaimer, the term of this
`patent is extended or adjusted under 35
`US.C. 154(b) by 0 days.
`
`.
`
`.
`(21) Appl. No.: 10/360,666
`(22)
`Filed:
`Feb. 6, 2003
`
`(65)
`
`Prior Publication Data
`US 2003/0144584 A1 Jul. 31, 2003
`
`Related U.S. Application Data
`
`(62) Division of application No. 09/939,391, filed on Aug. 24,
`2001, now abandoned.
`
`(30)
`
`Foreign Application Priority Data
`
`Oct. 5, 2000
`
`IL) vee ceeceeesecesseseeseecnseeeeseees 138884
`
`Tint. C07 eee cece eeeseeeeeeeeeeeeeeeeeeeeeneees A61B 5/00
`(SV)
`(52) U.S. Ch. cece 600/330; 600/322; 600/336
`(58) Field of Search oo... cece 600/310, 322,
`600/323, 330, 336
`
`(56)
`
`References Cited
`U.S. PATENT DOCUMENTS
`
`3,638,640 A
`3,799,672 A
`3,847,483 A
`3,998,550 A
`4,086,915 A
`4,167,331 A
`4,266,554 A
`4,357,105 A
`4,407,290 A
`4,446,871 A
`4,714,341 A
`
`2/1972 Shaw
`3/1974 Vurek oo. eeeeee 356/41
`11/1974 Shaw wee 356/41
`12/1976 Konishi et al... 356/39
`5/1978 Kofsky etal.
`9/1979 Nielsen ....... eee eeeeee 356/39
`5/1981 Hamaguri
`11/1982 Loretz woes 356/40
`10/1983. Wilber
`5/1984 Imura
`12/1987 Hamaguri et al.
`
`............ 356/41
`
`4,740,080 A
`4,773,422 A
`4,796,636 A
`4,802,486 A
`4,819,649 A
`4,819,752 A
`4,854,699 A
`4,859,057 A
`4,867,557 A
`4,892,101 A
`4,928,692 A
`4,934,372 A
`4,960,126 A
`5,190,038 A
`5,224,478 A
`5,348,004 A
`5,349,519 A
`
`........... 356/326
`
`4/1988 Donohueetal.
`9/1988 Isaacsonet al.
`1/1989 Branstetter et al.
`2/1989 Goodmanetal.
`4/1989 Rogersetal.
`4/1989 Zelin
`8/1989 Edgar, It. cece 356/41
`8/1989 Taylor ct al. ese 356/41
`
`al. oo... 356/41
`9/1989 Takatani
`et
`11990 Cheunget aL
`!
`5/1990 Goodmanetal.
`6/1990 Corenmanetal.
`10/1990 Conlon
`3/1993 Polsonetal.
`7/1993 Sakaietal.
`9/1994 Hollub
`9/1994 Kaestle ....... cee 364/413.09
`
`(List continued on next page.)
`FOREIGN PATENT DOCUMENTS
`
`WO
`WO
`WO
`
`2/1994
`W09403102
`8/2001
`WO00154573
`11/2001
`WO00184107
`OTHER PUBLICATIONS
`
`“Reflecance Pulse Oximetry at the Forehead of Newborns:
`The Influenece of Varying Pressure on the Probe”; A. Carin
`M. Dassel, MD, et el.; Dept of Obstetrics and Gynecology,
`Univ. Hospital Groningen, Groningen; Journal of Clinical
`Monitoring 12: pp. 421-428, 1996.
`(List continued on next page.)
`Primary Examiner—Enic F. Winakur
`(74) Attorney, Agent, or Firm—Howard & Howard
`(57)
`ABSTRACT
`
`A sensor for use in an optical measurement device and a
`method for non-invasive measurementof a blood parameter.
`The sensor includes sensor housing, a source of radiation
`coupled to the housing, and a detector assembly coupled to
`the housing. The source of radiation is adapted to emit
`radiation at predetermined frequencies. The detector assem-
`bly is adapted to detect reflected radiation at
`least one
`predetermined frequency and to generate respective signals.
`The signals are used to determine the parameterof the blood.
`
`5 Claims, 6 Drawing Sheets
`
`
`
`APPLE 1025
`
`APPLE 1025
`
`1
`
`

`

`US 6,801,799 B2
`
`Page 2
`
`U.S. PATENT DOCUMENTS
`
`5,355,880 A
`5,398,680 A
`5,413,100 A
`5,421,329 A
`5,482,036 A
`5,490,505 A
`5,490,506 A
`5,494,032 A *
`5,517,988 A
`5,533,507 A
`5,632,272 A
`5,645,060 A
`5,685,299 A
`5,758,644 A
`5,769,785 A
`5,782,237 A
`5,823,950 A
`5,842,981 A
`5,853,364 A
`5,919,134 A
`5,995,856 A
`6,011,986 A
`6,031,603 A
`6,036,642 A
`6,067,462 A
`6,081,735 A
`A
`6,083,172
`
`10/1994 Thomasetal.
`3/1995 Polsonetal.
`5/1995 Barthelemyet al.
`6/1995 Cascianietal.
`1/1996 Diab etal.
`2/1996 Diabetal.
`2/1996 Takataniet al.
`2/1996 Robinsonetal. ........... 600/323
`5/1996 Gerhard
`7/1996 Potratz
`5/1997 Diabetal.
`7/1997 Yorkey
`11/1997 Diab etal.
`6/1998 Diabetal.
`6/1998 Diab et al. 600/364
`7/1998 Cascianietal.
`10/1998 Diab et al. oo. 600/310
`12/1998 Larsen et al. we. 600/323
`12/1998 Baker, Jr. et al... 600/500
`FIV999 Diab oo... eee eeeeeeeeeeee 600/323
`11/1999 Mannheimeret al.
`...... 600/322
`1/2000 Diab et al. oe. 600/323
`2/2000 Fine et ab. oe. eee 356/41
`3/2000 Diab et al. oe. 600/364
`5/2000 Diab et al. oo... 600/310
`
`6/2000 Diab et al. oe. 600/310
`........... 600/500
`7/2000 Baker, Jr. et al.
`
`
`
`OTHER PUBLICATIONS
`
`“Reflectance Pulse Oximetry—Principles and Obstetric
`Application in the Zurich System”; Voker Konig, Renate
`Huch, and Albert Huch; Perinatal Physiology Research
`Dept., Dept. of Obstetrics, Computing 14: pp. 403-412,
`1998.
`
`“Effect of location of the sensor on reflectance pulse oxim-
`etry”; A.C. M. Dassel, Research Fellow et al. British Journal
`of Obstetrics and Gynecology; Aug. 1997, vol. 104, pp.
`910-916.
`
`“Design and Evaluation of a New Reflectance Pulse Oxime-
`ter Sensor”; Y. Mendelson, PhD, et al.; Worcester Polytech-
`nic Institute, Biomedical Engineering Program, Worcester,
`MA 01609; Association for the Advancement of Medical
`Instrumentation, vol. 22, No. 4, 1988; pp. 167-173.
`
`“Skin Reflectance Pulse Oximetry: In Vivo Measurements
`from the Forearm and Calf’; Y. Mednelson, PhD and M.J.
`McGinn, MSc; Dept. of Biomedical Engineering, Worcester
`Polytechnic Institute, Worcester, MA 01609; Journal of
`Clinical Monitoring, vol. 7, No. 1, 1991; pp. 7-12.
`
`“Experimental and Clinical Evaluation of a Noninvasive
`Reflectance Pulse Oximeter Sensor”; Setsuo Takatani, PhD,
`et al.; Dept. of Surgery, Baylor College of Medicine, One
`Baylor Plaza, Houston, TX 77030; Journal of Clinical
`Monitoring, vol. 8, No. 4, Oct. 1992; pp. 257-266.
`
`“Wavelength Selection for Low—Saturation Pulse Oxim-
`etry’; Paul D. Mannheimer, et al.; IEEE Transactions on
`Biomedical Engineering, vol. 44, No. 3, Mar. 1997; pp.
`148-158.
`
`“Noninvasive Pulse Oximetry Utilizing Skin Reflectance
`Photoplethysmography”; Yitzhak Mendelson and Burt D.
`Ochs; IEEE Transactions on Biomedical Engineering, vol.
`35, No. 10, Oct. 1988; pp. 798-805.
`
`“Physio—optical considerations in the design of fetal pulse
`oximetry sensors”; P.D. Mannheimer, M.E. Fein and J.R.
`Casciani; European Journal of Obstetrics & Gynecology and
`Reproductive Biology 72 Suppl. 1 (1997) S9-S19.
`
`“Fetal pulse oximetry: influence of tissue blood content and
`hemoglobin concentration in a new in-vitro model’; Tho-
`mas Edrich, Gerhard Rall, Reinhold Knitza; European Jour-
`nal if Obstetrics & Gynecology and Reproductive Biology
`72 Suppl. 1 (1997) S29-S34.
`
`* cited by examiner
`
`2
`
`

`

`U.S. Patent
`
`Oct. 5, 2004
`
`Sheet 1 of6
`
`US 6,801,799 B2
`
`HELOGLOBIN SPECTRA IN
`OXIMETRY
`
`COEFICIENT
`
`EXTINCTION
`
`500
`
`600
`
`700
`
`800
`
`900
`
`1000
`
`WAVELENGTH (nm)
`
`Figure 1
`
`CALIBRATION OF A PULSE OXIMETER
`
`100
`
`90
`
`80
`
`70
`
`60
`
`50
`
`40
`
`30
`
`20
`
`10
`
`
`
`OXYGENSATURATION
`
`0
`
`1.0
`
`2.0
`
`3.0
`
`4.0
`
`5.0
`
`R/IR RATIO
`Figure 2
`
`3
`
`

`

`U.S. Patent
`
`LIGHT
`EMITTING
`DIODES
`
`Sotoeee.
`
`Oct. 5, 2004
`
`Sheet 2 of6
`
`att
`eSSOOoTeaeekoeaPion
`
`Be ey ae US 6,801,799 B2
`
`4
`
`

`

`U.S. Patent
`
`Oct. 5, 2004
`
`Sheet 3 of6
`
`US 6,801,799 B2
`
`REFLECTION SENSOR
`
`
`SetasetAE
`eed:
`
`:
`
`e
`aety
`
`Figure 5A
`
`REFLECTION SENSOR
`
`
`
`
`
`
`
`5
`
`

`

`U.S. Patent
`
`Oct. 5, 2004
`
`Sheet 4 of6
`
`US 6,801,799 B2
`
`MICROPROCESSOR
`
`
`
`DISPLAY
`
`6
`
`

`

`U.S. Patent
`
`Oct. 5, 2004
`
`Sheet 5 of6
`
`US 6,801,799 B2
`
`
` ACCEPT DATA POINT
`
` REJECT DATA POINT
`COMPUTE WI, W2, W3 CALCULATE W/W;
`
`
`(NEAR AND FAR)
`
` REJECT POINT:
`
`TURN ON ALARM
`
`
`
`
`
`
`NO
`
`ACCEPT POINT:
`
`(ADJUST SENSOR POSITION) GO TO STEP 3 Figure 10A
`
`7
`
`

`

`U.S. Patent
`
`Oct. 5, 2004
`
`Sheet 6 of6
`
`US 6,801,799 B2
`
`
` REJECT POINT:
`Is
`THE QUALITY OF EACH
`
`TURN ON ALARM
`PHOTOPLETHYSMOGRAM
`(MOVEMENT/BREATHINGARTIFACTS)
`
`ACCEPTABLE
`
`
`?
`
` YES
`
`
`
`
`ACCEPT POINT:
`
`GOTO STEP 3
`
`Figure 10B
`
`
`
`CALCULATE W, /W.
`AND W, /W,
`(NEAR AND FAR)
`
` REJECT POINT:
`
`
`
` TAKE ANOTHER
`MEASUREMENT
`
`?
`
`
`
`
`
`
`Figure10C_
` ACCEPTPOINT:
`
`COMPUTE AND UPDATE
`
`DISPLAY WITH NEW SpO7 VALUE
`
`
`8
`
`

`

`US 6,801,799 B2
`
`1
`PULSE OXIMETER AND METHOD OF
`OPERATION
`
`This application is a divisional application of U.S. patent
`application Ser. No. 09/939,391 filed Aug. 24, 2001, now
`abandoned.
`
`BACKGROUND OF THE INVENTION
`
`1. Field of the Invention
`
`This invention is generally in the field of pulse oximetry,
`and relates to a sensor for use in a pulse oximeter, and a
`method for the pulse oximeter operation.
`2. Background of the Invention
`Oximetry is based on spectrophotometric measurements
`of changes in the color of blood, enabling the non-invasive
`determination of oxygen saturation in the patient’s blood.
`Generally, oximetry is based on the fact that the optical
`property of blood in the visible (between 500 and 700 nm)
`and near-infrared (between 700 and 1000 nm) spectra
`depends strongly on the amount of oxygen in blood.
`Referring to FIG. 1,
`there is illustrated a hemoglobin
`spectra measured by oximetry based techniques. Graphs G1
`and G2 correspond, respectively, to reduced hemoglobin, or
`deoxyhemoglobin (Hb), and oxygenated hemoglobin, or
`oxyhemoglobin (HbO.,), spectra. As shown, deoxyhemoglo-
`bin (Hb) has a higher optical extinction (i.e., absorbs more
`light) in the red region of spectrum around 660 nm, as
`compared to that of oxyhemoglobin (HbO,). On the other
`hand,in the near-infrared region of the spectrum around 940
`om,
`the optical absorption by deoxyhemoglobin (Hb) is
`lowerthan the optical absorption of oxyhemoglobin (HbO.).
`Prior art non-invasive optical sensors for measuring arte-
`rial oxyhemoglobin saturation (SaO,) by a pulse oximeter
`(termed SpO.,) are typically comprised ofa pair of small and
`inexpensive light emitting diodes (LEDs), and a single
`highly sensitive silicon photodetector. A red (R) LED cen-
`tered on a peak emission wavelength around 660 nm and an
`infrared (IR) LED centered on a peak emission wavelength
`around 940 nm are used as light sources.
`Pulse oximetry relies on the detection of a photoplethys-
`mographic signal caused by variations in the quantity of
`arterial blood associated with periodic contraction and relax-
`ation of a patient’s heart. The magnitude of this signal
`depends on the amountof blood ejected from the heart into
`the peripheral vascular bed with each systolic cycle,
`the
`optical absorption of the blood, absorption by skin andtissue
`components, and the specific wavelengths that are used to
`illuminate the tissue. SaO. is determined by computing the
`relative magnitudes of the R and IR photoplethysmograms.
`Electronic circuits inside the pulse oximeter separate the R
`and IR photoplethysmogramsinto their respective pulsatile
`(AC) and non-pulsatile (DC) signal components. An algo-
`rithm inside the pulse oximeter performs a mathematical
`normalization by which the time-varying AC signal at each
`wavelength is divided by the corresponding time-invariant
`DC componentwhich results mainly from the light absorbed
`and scattered by the bloodless tissue, residual arterial blood
`when the heart is in diastole, venous blood and skin pig-
`mentation.
`
`Since it is assumed that the AC portion results only from
`the arterial blood component, this scaling process provides
`a normalized R/IR ratio (i.e., the ratio of AC/DC values
`corresponding to R- and IR-spectrum wavelengths,
`respectively), which is highly dependent on SaO., but is
`largely independentof the volumeofarterial blood entering
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`40
`
`45
`
`50
`
`55
`
`60
`
`65
`
`2
`the tissue during systole, skin pigmentation, skin thickness
`and vascular structure. Hence, the instrument does not need
`to be re-calibrated for measurements on different patients.
`Typical calibration of a pulse oximeteris illustrated in FIG.
`2 by presenting the empirical relationship between SaO, and
`the normalized R/IR ratio, which is programmed by the
`pulse oximeters’ manufacturers.
`Pulse oximeters are of two kinds operating, respectively,
`in transmission andreflection modes. In transmission-mode
`pulse oximetry, an optical sensor for measuring SaO, is
`usually attached across a fingertip, foot or earlobe, such that
`the tissue is sandwiched between the light source and the
`photodetector.
`In reflection-mode or backscatter type pulse oximetry, as
`shown in FIG. 3,
`the LEDs and photodetector are both
`mounted side-by-side next to each other on the same planar
`substrate. This arrangement allows for measuring SaO, from
`multiple convenient locations on the body (e.g. the head,
`torso, or upper limbs), where conventional transmission-
`mode measurements are not feasible. For this reason, non-
`invasive reflectance pulse oximetry has recently become an
`important new clinical technique with potential benefits in
`fetal and neonatal monitoring. Using reflectance oximetry to
`monitor SaO,
`in the fetus during labor, where the only
`accessible location is the fetal scalp or cheeks, or on the
`chest
`in infants with low peripheral perfusion, provides
`several more convenient locations for sensor attachment.
`
`Reflection pulse oximetry, while being based on similar
`spectrophotometric principles as the transmission one, is
`more challenging to perform and has unique problemsthat
`can not always be solved by solutions suitable for solving
`the problems associated with the transmission-mode pulse
`oximetry. Generally, comparing transmission and reflection
`pulse oximetry,
`the problems associated with reflection
`pulse oximetry consist of the following:
`In reflection pulse oximetry, the pulsatile AC signals are
`generally very small and, depending on sensor configuration
`and placement, have larger DC components as compared to
`those of transmission pulse oximetry. As illustrated in FIG.
`4, in addition to the optical absorption and reflection due to
`blood, the DC signal of the R and IR photoplethysmograms
`in reflection pulse oximetry can be adversely affected by
`strong reflections from a bone. This problem becomes more
`apparent when applying measurements at such body loca-
`tions as the forehead and the scalp, or when the sensor is
`mounted on the chest over the ribcage. Similarly, variations
`in contact pressure between the sensor and the skin can
`causelarger errors in reflection pulse oximetry (as compared
`to transmission pulse oximetry) since someof the blood near
`the superficial layers of the skin may be normally displaced
`away from the sensor housing towards deeper subcutaneous
`structures. Consequently,
`the highly reflective bloodless
`tissue compartment near the surface of the skin can cause
`large errors even at body locations where the boneis located
`too far away to influence the incident light generated by the
`sensor.
`
`Another problem with currently available reflectance sen-
`sors is the potential for specular reflection caused by the
`superficial layers of the skin, when an air gap exists between
`the sensor and the skin, or by direct shunting of light
`between the LEDsand the photodetector through a thin layer
`of fluid which may be due to excessive sweating or from
`amniotic fluid present during delivery.
`It is important to keep in mind the two fundamental
`assumptions underlying the conventional dual-wavelength
`pulse oximetry, which are as follows:
`
`9
`
`

`

`US 6,801,799 B2
`
`3
`illuminating
`(1) the path of light rays with different
`wavelengths in tissue are substantially equal and, therefore,
`cancel each other; and (2) each light source illuminates the
`same pulsatile change in arterial blood volume.
`Furthermore,
`the correlation between optical measure-
`ments and tissue absorptions in pulse oximetry are based on
`the fundamental assumption that light propagation is deter-
`mined primarily by absorbable due to Lambent-Beer’s law
`neglecting multiple scattering effects in biologicaltissues. In
`practice, however, the optical paths of different wavelengths
`in biological tissues is known to vary more in reflectance
`oximetry compared to transmission oximetry, since it
`strongly depends on the light scattering properties of the
`illuminated tissue and sensor mounting.
`Several human validation studies, backed by animal
`investigations, have suggested that uncontrollable physi-
`ological and physical parameters can cause large variations
`in the calibration curve of reflectance pulse oximeters pri-
`marily at low oxygen saturation values below 70%. It was
`observed that the accuracy of pulse oximeters in clinical use
`might be adversely affected by a number of physiological
`parameters when measurements are made from sensors
`attached to the forehead, chest, or the buttock area. While the
`exact sources of these variations are not fully understood,it
`is generally believed that there are a few physiological and
`anatomical factors that may be the major source of these
`errors.It is also well known for example that changesin the
`ratio of blood to bloodless tissue volumes may occur
`through venous congestion, vasoconstriction/vasodilatation,
`or through mechanical pressure exerted by the sensor on the
`skin.
`
`Additionally, the empirically derived calibration curve of
`a pulse oximeter can be altered by the effects of contact
`pressure exerted by the probe on the skin. This is associated
`with the following. The light paths in reflectance oximetry
`are not well defined (as comparedto transmission oximetry),
`and thus may differ between the red and infrared wave-
`lengths. Furthermore, the forehead and scalp areas consist of
`a relatively thin subcutaneous layer with the cranium bone
`undemeath, while the tissue of other anatomical structures,
`such as the buttock and limbs, consists of a much thicker
`layer of skin and subcutaneous tissues without a nearby
`bony support that acts as a strong lightreflector.
`Several in vivo and in vitro studies have confirmed that
`uncontrollable physiological and physical parameters(e.g.,
`different amounts of contact pressure applied by the sensor
`on the skin, variation in the ratio of bloodless tissue-to-blood
`content, or site-to-site variations) can often cause large
`errors in the oxygen saturation readings of a pulse oximeter,
`which are normally derived based on a single internally-
`programmed calibration curve. The relevant in vivo studies
`are disclosed in the following publications:
`1. Dassel, et al., “Effect of location of the sensor on
`reflectance pulse oximetry”, British Journal of Obstetrics
`and Gynecology, vol. 104, pp. 910-916, (1997);
`the
`2. Dassel, et al., “Reflectance pulse oximetry at
`forehead of newborns: The influence of varying pressure on
`the probe”, Journal of Clinical Monitoring, vol. 12, pp.
`421-428, (1996).
`The relevantin vitro studies are disclosed, for example in
`the following publication:
`3. Edrich et al., “Fetal pulse oximetry: influence of tissue
`blood content and hemoglobin concentration in a new
`in-vitro model”, European Journal of Obstetrics and Gyne-
`cology and Reproductive Biology, vol. 72, suppl. 1, pp.
`$29-S34, (1997).
`
`4
`Improved sensors for application in dual-wavelength
`reflectance pulse oximetry have been developed. As dis-
`closed in the following publication: Mendelson, et al.,
`“Noninvasive pulse oximetry utilizing skin reflectance
`photoplethysmography”, IEEE Transactions on Biomedical
`Engineering, vol. 35, no. 10, pp. 798-805 (1988), the total
`amount of backscattered light that can be detected by a
`reflectance sensoris directly proportional to the numberof
`photodetectors placed around the LEDs. Additional
`improvements in signal-to-noise ratio were achieved by
`increasing the active area of the photodetector and optimiz-
`ing the separation distance between the light sources and
`photodetectors.
`Another approach is based on the use of a sensor having
`six photodiodes arranged symmetrically around the LEDs
`that is disclosed in the following publications:
`4. Mendelson, et al., “Design and evaluation of a new
`reflectance pulse oximeter sensor”, Medical
`Instrumentation, vol. 22, no. 4, pp. 167-173 (1988); and
`5. Mendelson,et al., “Skin reflectance pulse oximetry: in
`vivo measurements from the forearm and calf’, Journal of
`Clinical Monitoring, vol. 7, pp. 7-12, (1991).
`According to this approach, in order to maximize the
`fraction of backscattered light collected by the sensor, the
`currents from all six photodiodes are summedelectronically
`by internal circuitry in the pulse oximeter. This configuration
`essentially creates a large area photodetector made of six
`discrete photodiodes connected in parallel
`to produce a
`single current that is proportional to the amount of light
`backscattered from the skin. Several studies showedthat this
`sensor configuration could be used successfully to accu-
`rately measure SaO, from the forehead, forearm andthe calf
`on humans. However,
`this sensor requires a means for
`heating the skin in order to increase local blood flow, which
`has practical limitations since it could cause skin burns.
`Yet another prototype reflectance sensor is based on eight
`dual-wavelength LEDs and a single photodiode, and is
`disclosed in the following publication: Takatani et al.,
`“Experimental and clinical evaluation of a noninvasive
`reflectance pulse oximeter sensor”, Journal of Clinical
`Monitoring, vol. 8, pp. 257-266 (1992). Here, four R and
`four IR LEDs are spaced at 90-degree intervals around the
`substrate and at an equal radial distance from the photo-
`diode.
`
`A similar sensor configuration based on six photodetec-
`tors mounted in the center of the sensor around the LEDsis
`
`disclosed in the following publication: Konig, et al.,
`“Reflectance pulse oximetry—principles and obstetric appli-
`cation in the Zurich system”, Journal of Clinical Monitoring,
`vol. 14, pp. 403-412 (1998).
`According to the techniques disclosed in all of the above
`publications, only LEDs of two wavelengths, R and IR,are
`used as light sources, and the computation of SaO, is based
`on reflection photoplethysmograms measured by a single
`photodetector, regardless of whether one or multiple photo-
`diodes chips are used to construct the sensor. This is because
`of the fact that the individual signals from the photodetector
`elements are all summed together electronically inside the
`pulse oximeter. Furthermore, while a radially-symmetric
`photodetector array can help to maximize the detection of
`backscattered light from the skin and minimize differences
`from local tissue inhomogeneity, human and animal studies
`confirmed that this configuration can not completely elimi-
`nate errors caused by pressure differences and site-to-site
`variations.
`
`The use of a nominal dual-wavelength pair of 735/890 nm
`was suggested as providing the best choice for optimizing
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`40
`
`45
`
`55
`
`60
`
`65
`
`10
`
`10
`
`

`

`US 6,801,799 B2
`
`5
`accuracy, as well as sensitivity in dual-wavelength reflec-
`tance pulse oximetry,
`in U.S. Pat. Nos. 5,782,237 and
`5,421,329. This approach minimizes the effects of tissue
`heterogeneity and enables to obtain a balance in path length
`changes arising from perturbations in tissue absorbance.
`This is disclosed in the following publications:
`6. Mannheimerat al., “Physio-optical considerations in
`the design of fetal pulse oximetry sensors”, European Jour-
`nal of Obstetrics and Gynecology and Reproductive
`Biology, vol. 72, suppl. 1, pp. S9-S19, (1997); and
`7. Mannheimer at al., “Wavelength selection for low-
`saturation pulse oximetry”, IEEE Transactions on Biomedi-
`cal Engineering, vol. 44, no. 3, pp. 48-158 (1997)].
`However, replacing the conventional R wavelength at 660
`nm, which coincides with the region of the spectrum where
`the difference between the extinction coefficient of Hb and
`
`10
`
`15
`
`20
`
`30
`
`35
`
`40
`
`6
`pulse oximeter between subjects, since perturbations caused
`by contact pressure remain one of the major sources of errors
`in reflectance pulse oximetry. In fetal pulse oximetry, there
`are additional factors, which must be properly compensated
`for in order to produce an accurate and reliable measurement
`of oxygen saturation. For example, the fetal head is usually
`the presenting part, and is a rather easily accessible location
`for application of reflectance pulse oximetry. However,
`uterine contractions can cause large and unpredictable varia-
`tions in the pressure exerted on the head and by the sensor
`on the skin, which can lead to large errors in the measure-
`ment of oxygen saturation by a dual-wavelength reflectance
`pulse oximeter. Another object of the invention is to provide
`accurate measurement of oxygen saturation in the fetus
`during delivery.
`The basis for the errors in the oxygen saturation readings
`of a dual-wavelength pulse oximeter is the fact that,
`in
`HbO,is maximal, with a wavelength emitting at 735 nm,not
`practical situations, the reflectance sensor applications affect
`only lowers considerably the overall sensitivity of a pulse
`the distribution of blood in the superficial layers of the skin.
`oximeter, but does not completely eliminate errors due to
`This is different from an ideal situation, when a reflectance
`sensor placement and varying contact pressures.
`sensor measures light backscattered from a homogenous
`mixture of blood and bloodless tissue components.
`Pulse oximeter probes of a type comprising three or more
`Therefore, the R and IR DC signals practically measured by
`LEDs for filtering noise and monitoring other functions,
`photodetectors containarelatively larger proportion oflight
`such as carboxyhemoglobin or various indicator dyes
`25
`absorbed by and reflected from the bloodless tissue com-
`injected into the blood stream, have been developed and are
`partments. In these uncontrollable practical situations, the
`disclosed, for example, in WO 00/32099 and U.S. Pat. No.
`changes caused are normally not compensated for automati-
`5,842,981. The techniques disclosed in these publications
`cally by calculating the normalized RAR ratio since the AC
`are aimed at providing an improved methodfordirect digital
`portions of each photoplethysmogram,and the correspond-
`signal formation from input signals produced by the sensor
`ing DC components, are affected differently by pressure or
`and for filtering noise.
`site-to-site variations. Furthermore, these changes depend
`Noneof the aboveprior art techniques providesa solution
`to overcome the most essential
`limitation in reflectance
`not only on wavelength, but depend also on the sensor
`geometry, and thus cannot be eliminated completely by
`pulse oximetry, which requires the automatic correction of
`the internal calibration curve from which accurate and
`computing the normalized R/IRratio, as is typically the case
`in dual-wavelength pulse oximeters.
`reproducible oxygen saturation values are derived, despite
`The inventor has found that the net result of this nonlinear
`variations in contact pressure or site-to-site tissue heteroge-
`effect is to cause large variations in the slope of the cali-
`neity.
`bration curves. Consequently, if these variations are not
`In practice, most sensors used in reflection pulse oximetry
`compensated automatically, they will cause large errors in
`rely on closely spaced LED wavelengths in order to mini-
`the final computation of SpO., particularly at low oxygen
`mize the differences in the optical path lengths of the
`saturation levels normally found in fetal applications.
`different wavelengths. Nevertheless, within the wavelength
`Another object of the present invention is to compensate
`range required for oximetry, even closely spaced LEDs with
`for these variations and to provide accurate measurementof
`closely spaced wavelengths mounted on the same substrate
`oxygen saturation. The invention consists of, in addition to
`can lead to large random errorin the final determination of
`two measurement sessions typically carried out in pulse
`SaO,,.
`oximetry based on measurements with two wavelengths
`centered around the peak emission values of 660 nm (red
`spectrum) and 940 nm+20 nm (IR spectrum), one additional
`measurementsession is carried out with an additional wave-
`
`SUMMARYOF THE INVENTION AND
`ADVANTAGES
`
`45
`
`The object of the invention is to provide a novel sensor
`design and method that functions to correct the calibration
`relationship of a reflectance pulse oximeter, and reduce
`measurement inaccuracies in general. Another object of the
`invention is to provide a novel sensor and method that
`functions to correct the calibration relationship of a reflec-
`tance pulse oximeter, and reduce measurementinaccuracies
`in the lower range of oxygen saturation values (typically
`below 70%), which is the predominantrange in neonatal and
`fetal applications.
`Yet another object of the present invention is to provide
`automatic correction of the internal calibration curve from
`
`which oxygen saturation is derived inside the oximeter in
`situations wherevariations in contact pressure orsite-to-site
`tissue heterogeneity may cause large measurement inaccu-
`racies.
`
`Another object of the invention is to eliminate or reduce
`the effect of variations in the calibration of a reflectance
`
`least one additional wavelength is preferably
`length. At
`chosen to be substantially in the IR region of the electro-
`magnetic spectrum,i.e., in the NIR-IR spectrum (having the
`peak emission value above 700 nm). In a preferred embodi-
`ment
`the use of at
`least
`three wavelengths enables the
`calculation of an at least one additional ratio formed by the
`combination of the two IR wavelengths, which is mostly
`dependent on changes in contact pressure or site-to-site
`variations. In a preferred embodiment, slight dependence of
`the ratio on variations in arterial oxygen saturation that may
`occur, is easily minimized or eliminated completely, by the
`proper selection and matching of the peak emission wave-
`lengths and spectral characteristics of the at
`least
`two
`IR-light sources.
`Preferably, the selection of the IR wavelengthsis based on
`certain criteria. The IR wavelengths are selected to coincide
`with the region of the optical absorption curve where HbO,
`absorbsslightly more light than Hb. The IR wavelengthsare
`
`50
`
`55
`
`60
`
`65
`
`11
`
`11
`
`

`

`US 6,801,799 B2
`
`7
`in the spectral regions where the extinction coefficients of
`both Hb and HbO, are nearly equal and remain relatively
`constant as a function of wavelength, respectively.
`In a preferred embodiment, tracking changesin the ratio
`formed by the two IR wavelengths, in real-time, permits
`automatic correction of errors in the normalized ratio
`obtained from the R-wavelength and each of the
`IR-wavelengths. The term “ratio” signifies the ratio of two
`values of AC/DC corresponding to two different wave-
`lengths. This is similar to adding another equation to solve
`a problem with at least three unknowns (i.e., the relative
`concentrations of HbO, and Hb, whichare used to calculate
`SaO., and the unknown variable fraction of blood-to-tissue
`volumesthat effects the accurate determination of SaO.),
`which otherwise must rely on only two equations in the case
`of only two wavelengths used in conventional dual-
`wavelength pulse oximetry. In a preferred embodiment, a
`third wavelength provides the added ability to compute
`SaO, based on the ratio formed from the R-wavelength and
`either of the IR-wavelengths. In a preferred embodiment,
`changes in these ratios are tracked and compared in real-
`time to determine which ratio produces a more stable or less
`noisy signal. That ratio is used predominantly for calculating
`SaO,,.
`The present invention utilizes collection of light reflected
`from the measurementlocation at different detection loca-
`
`tions arranged along a closed path around light emitting
`elements, which can be LEDsor laser sources. Preferably,
`these detection locations are arranged in two concentric
`rings, the so-called “near” and “far” rings, around the light
`emitting elements. This arrangement enables optimal posi-
`tioning of the detectors for high quality measurements, and
`enables discrimination between photodetectors receiving
`“good” information (i.e., AC and DC values which would
`result in accurate calculations of SpO.) and “bad” informa-
`tion (i.e., AC and DC values which would result in inaccu-
`rate calculations of SpO,).
`There is thus provided according to one aspect of the
`present invention, a sensor for use in an optical measurement
`device for non-invasive measurements of blood parameters,
`the sensor comprising:
`(1) a light source for illuminating a measurementlocation
`with incident light of at least three wavelengths, the first
`wavelength lying in a red (R) spectrum, and the at least
`second and third wavelengths lying substantially in the
`infrared (IR) spectrum; and
`(2) a detector assembly for detecting light returned from
`the illuminated location,
`the detector assembly being
`arranged so as to define a plurality of detection locations
`along at least one closed path around the light source.
`The term “closed path” used herein signifies a closed
`curve, like a ring, ellipse, or polygon, and the like.
`The detector assembly is comprised of at least one array
`of discrete detectors (e.g., photodiodes) accommodated
`along at least one closed path, or at least one continuous
`photodetector defining the closed path.
`The term “substantially IR spectrum” used herein signi-
`fies a spectrum range including near infrared and infrared
`regions.
`invention,
`According to another aspect